Fibromyalgia Complicating Disease Management in Rheumatoid Arthritis
Creators
- 1. The Indus Hospital, Karachi (Pakistan). Dept. of Medicine
- 2. Sindh Inst. of Urology and Transplantation, Karachi (Pakistan). Dept. of Medicine
Description
Objective: To evaluate frequency of fibromyalgia in rheumatoid arthritis and its effect on disease activity score. Study Design: Cross-sectional study. Place and Duration of Study: The Indus Hospital, Karachi, from December 2010 to May 2011. Methodology: All adult patients of either gender diagnosed as rheumatoid arthritis on the basis of clinical, laboratory and X-ray criteria were included in the study. The sample data was separated into two groups depending on presence or absence of fibromyalgia and 28 joint disease activity score (DAS-28) value was evaluated. Results: There were 31 (25.83%) patients with rheumatoid arthritis and fibromyalgia (RAFM) out of the total 120. The median (IQR) age of patients was 40 (32 - 51) years. All were females. The overall female frequency was 79 (88.8%). The median (IQR) DAS-28 score in RA group was 4.9 (3.66 - 5.71), while the median (IQR) DAS-28 score in RAFM was 7.04 (6.62 - 7.64) [p < 0.0001]. The number of patient getting combination therapy of DMARD in RAFM group was 61.3% while in RA group was 42.7%. Conclusion: DAS-28 was found to be significantly higher in RAFM patients probably because of higher perception of pain. (author)
Additional details
Publishing Information
- Journal Title
- JCPSP. Journal of the College of Physicians and Surgeons Pakistan
- Journal Volume
- 24
- Journal Issue
- 6
- Journal Page Range
- p. 424-427
- ISSN
- 1022-386X
INIS
- Country of Publication
- Pakistan
- Country of Input or Organization
- Pakistan
- INIS RN
- 45076036
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ADULTS; BONE JOINTS; COMBINED THERAPY; COMPARATIVE EVALUATIONS; PAIN; RHEUMATIC DISEASES; SKELETAL DISEASES
- Descriptors DEC
- AGE GROUPS; BODY; DISEASES; EVALUATION; MEDICINE; ORGANS; SKELETON; SYMPTOMS; THERAPY